Go to PegaPoll
PEGAPOLL · NEWS

Flickering light and sound therapy fails to slow Alzheimer’s in long-awaited trial

Nature News · 2026-11-17
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.

A home device meant to slow Alzheimer’s disease with flickering light and rhythmic clicking sounds did not outperform a sham in a year-long trial, Cognito Therapeutics of Cambridge, Massachusetts, reported on 16 November at the Clinical Trials on Alzheimer’s Disease meeting in Boston. Spectris AD pairs goggles with headphones worn for 60 minutes a day; the stimulation is intended to drive gamma brain waves, activity previously linked to attention and memory.

In the study, 673 people with Alzheimer’s disease were randomly assigned to an active or sham device for 12 months. On a 156-point scale of cognition and daily function, those on the active device scored 8.97 points worse after a year; sham users declined by 8.82 points. There was no cognitive improvement versus sham.

Chief executive Christian Howell said the company still saw encouraging signs in people with mild cognitive impairment and plans to seek US Food and Drug Administration approval next year, calling the mild-subgroup effect “so meaningful.” Independent neurologist Eric McDade of Washington University School of Medicine in St. Louis, who was not involved in the trial, judged it negative and said any next step should be a dedicated follow-up study in that milder population.

Continue in the app — vote & join in ➔
Source: Nature News · via ahirlevel.hu

Related news